Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lisette Nixon"'
Autor:
Dean A. Fennell, Catharine Porter, Jason Lester, Sarah Danson, Fiona Blackhall, Marianne Nicolson, Lisette Nixon, Georgina Gardner, Ann White, Gareth Griffiths, Angela Casbard
Publikováno v:
EClinicalMedicine, Vol 52, Iss , Pp 101595- (2022)
Summary: Background: Impaired double strand DNA repair by homologous repair deficiency (HRD) leads to sensitivity to poly ADP ribose polymerase (PARP) inhibition. Poly-ADP ribose polymerase (PARP) inhibitors target HRD to induce synthetic lethality a
Externí odkaz:
https://doaj.org/article/5eac60aa60c74467a5e326d9acef200e
Autor:
Dean A. Fennell, Catharine Porter, Jason Lester, Sarah Danson, Paul Taylor, Michael Sheaff, Robin M Rudd, Aarti Gaba, Sara Busacca, Lisette Nixon, Georgina Gardner, Liz Darlison, Charlotte Poile, Cathy Richards, Peter-Wells Jordan, Gareth Griffiths, Angela Casbard
Publikováno v:
EClinicalMedicine, Vol 48, Iss , Pp 101432- (2022)
Summary: Background: Currently, there is no US Food and Drug Administration approved therapy for patients with pleural mesothelioma who have relapsed following platinum-doublet based chemotherapy. Vinorelbine has demonstrated useful clinical activity
Externí odkaz:
https://doaj.org/article/0113ef74d70c46c8adefcb4b8bf610e3
Autor:
Douglas Adamson, Jane Blazeby, Catharine Porter, Christopher Hurt, Gareth Griffiths, Annmarie Nelson, Bernadette Sewell, Mari Jones, Martina Svobodova, Deborah Fitzsimmons, Lisette Nixon, Jim Fitzgibbon, Stephen Thomas, Anthony Millin, Tom Crosby, John Staffurth, Anthony Byrne
Publikováno v:
Health Technology Assessment, Vol 25, Iss 31 (2021)
Background: Most patients with oesophageal cancer present with incurable disease. For those with advanced disease, the mean survival is 3–5 months. Treatment emphasis is therefore on effective palliation, with the majority of patients requiring int
Externí odkaz:
https://doaj.org/article/e9af995b9a6642c687a23a2446f6c8f4
Autor:
Lucy Wills, Rhydian Maggs, Geraint Lewis, Gareth Jones, Lisette Nixon, John Staffurth, Tom Crosby, on behalf of the SCOPE 1 trial management group and collaborators
Publikováno v:
Radiation Oncology, Vol 12, Iss 1, Pp 1-10 (2017)
Abstract Background SCOPE 1 was the first UK based multi-centre trial involving radiotherapy of the oesophagus. A comprehensive radiotherapy trials quality assurance programme was launched with two main aims: 1. To assist centres, where needed, to ad
Externí odkaz:
https://doaj.org/article/ae886830ae5441a2906f28395a6d9cab
Autor:
Somnath Mukherjee, Christopher Nicholas Hurt, Richard A. Adams, Andrew Bateman, Kevin Bradley, Sarah Bridges, Stephen Falk, Gareth Griffiths, Sarah Gwynne, Christopher Jones, Philip Markham, Tim Maughan, Lisette Nixon, Ganesh Radhakrishna, Rajarshi Roy, Simon Schoenbuchner, Hamid Sheikh, Emiliano Spezi, Maria Hawkins, Tom Crosby
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ca8ed5984fa1dc6a837fdc8a8f3c067
https://doi.org/10.2139/ssrn.4380032
https://doi.org/10.2139/ssrn.4380032
Autor:
Emma Higgins, Nachi Palaniappan, Zohal Nabi, Kate Elliott, Liz Miles, Rikki Lad, Lisette Nixon, Jo Canham, Chris Hurt, Christie Heiberg, Matthew Beasley, Terry Jones, Richard Webster, Mererid Evans
Publikováno v:
Clinical Oncology. 34:e16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b0691efe2a15739db0732f7c5330df5
https://doi.org/10.1016/j.clon.2022.09.029
https://doi.org/10.1016/j.clon.2022.09.029